bluebird stockholders to receive $3.00 per share in cash and a contingent value right of $6.84 per share in cash payable upon achievement of a net sales milestone, contingent upon offer conditions ...

Bluebird bio to be acquired by Carlyle Group & SK Capital, offering up to $9.84/share based on product performance. Former Mirati CEO David Meek set to lead bluebird post-acquisition, with deal ...

By Margaret Lyons Nothing is fair in love or war in the fast-paced Polish spy drama “The Eastern Gate” (in Polish and Russian, with subtitles or dubbed). The show, on Max, is intense ...

Play the USA TODAY Daily Crossword Puzzle. There also are prints of a bluebird altered by Susan Monroe Kalb and Mike who added the eastern bluebird touch. An envelope of 24 of these prints was ...

Over the late fall and into the winter, the Eastern Bluebird mural has been taking shape on the side of the 4 Girls And A ...

MANILA, Philippines — An earthquake with a magnitude of 5.5 rocked Eastern Visayas on Saturday morning, said the Philippine Institute of Volcanology and Seismology (Phivolcs). According to the ...

Bluebird’s lead CAR-T cancer cell therapy idecabtagene vicleucel (ide-cel) was last year hit with an FDA refuse-to-file letter, which required additional data on chemistry, manufacturing and ...

Ethan Day, Revere — Entering his final high school game 65 points shy of 1,000 for his career, the senior captain scored exactly 65 in Tuesday’s 80-53 rout of Northeast in the consolation game ...

WARSAW/RIGA, Feb 19 (Reuters) - Polish call centre worker Katarzyna Paprota, 48, says the dramatic shift in United States policy towards Russia and Ukraine under President Donald Trump gives her ...

Rwanda-backed rebels tightened their grip on Bukavu on Monday, a day after seizing the second major city in eastern Democratic Republic of Congo whose residents appeared resigned to their fate ...

Panic swept through eastern Congo's second-largest city on Saturday as residents fled by the thousands, scrambling to escape the looming advance of Rwanda-backed rebels. The morning after M23 ...

As bluebird bio struggles to get its gene therapies over the finishing line, the company says its financial position raises "substantial doubt" about its ability to continue as a going concern.